Terms: = Endocrine gland cancer AND FOXO3, FKHRL1, 2309, ENSG00000118689, MGC31925, MGC12739, FOXO2, FOXO3A, O43524, AF6q21, FKHRL1P2, DKFZp781A0677 AND Prognosis
21 results:
1. Nuclear MAST4 Suppresses foxo3 through Interaction with AKT3 and Induces Chemoresistance in Pancreatic Ductal Carcinoma.
Fujiwara-Tani R; Sasaki T; Bhawal UK; Mori S; Ogata R; Sasaki R; Ikemoto A; Kishi S; Fujii K; Ohmori H; Sho M; Kuniyasu H
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612866
[TBL] [Abstract] [Full Text] [Related]
2. Screening and Identification of a Prognostic Model of Ovarian cancer by Combination of Transcriptomic and Proteomic Data.
Jiang J; Chen Z; Wang H; Wang Y; Zheng J; Guo Y; Jiang Y; Mo Z
Biomolecules; 2023 Apr; 13(4):. PubMed ID: 37189432
[TBL] [Abstract] [Full Text] [Related]
3. Correlation of DNA methylation and lymph node metastasis in papillary thyroid carcinoma.
Zhao F; Zhu S; Fang J; Dong H; Zhu C
Head Neck; 2023 Jul; 45(7):1654-1662. PubMed ID: 37097909
[TBL] [Abstract] [Full Text] [Related]
4. Pancancer analysis of SKA1 mutation and its association with the diagnosis and prognosis of human cancers.
Lan H; Yuan J; Zhang R; Jiang B; Li Q; Huang Z; Chen P; Xiang H; Zeng X; Xiao S
Genomics; 2023 Mar; 115(2):110554. PubMed ID: 36587749
[TBL] [Abstract] [Full Text] [Related]
5. RBM47/SNHG5/foxo3 axis activates autophagy and inhibits cell proliferation in papillary thyroid carcinoma.
Qin Y; Sun W; Wang Z; Dong W; He L; Zhang T; Lv C; Zhang H
Cell Death Dis; 2022 Mar; 13(3):270. PubMed ID: 35338124
[TBL] [Abstract] [Full Text] [Related]
6. SIRT1 coordinates with the CRL4B complex to regulate pancreatic cancer stem cells to promote tumorigenesis.
Leng S; Huang W; Chen Y; Yang Y; Feng D; Liu W; Gao T; Ren Y; Huo M; Zhang J; Yang Y; Wang Y
Cell Death Differ; 2021 Dec; 28(12):3329-3343. PubMed ID: 34163012
[TBL] [Abstract] [Full Text] [Related]
7. SLC34A2 simultaneously promotes papillary thyroid carcinoma growth and invasion through distinct mechanisms.
He J; Zhou M; Li X; Gu S; Cao Y; Xing T; Chen W; Chu C; Gu F; Zhou J; Jin Y; Ma J; Ma D; Zou Q
Oncogene; 2020 Mar; 39(13):2658-2675. PubMed ID: 32005974
[TBL] [Abstract] [Full Text] [Related]
8. Valproic Acid Addresses Neuroendocrine Differentiation of LNCaP Cells and Maintains Cell Survival.
Giordano F; Naimo GD; Nigro A; Romeo F; Paolì A; De Amicis F; Vivacqua A; Morelli C; Mauro L; Panno ML
Drug Des Devel Ther; 2019; 13():4265-4274. PubMed ID: 31908413
[TBL] [Abstract] [Full Text] [Related]
9. Expression of the PTEN/foxo3a/PLZF signalling pathway in pancreatic cancer and its significance in tumourigenesis and progression.
Zhang Q; Li X; Li Y; Chen S; Shen X; Dong X; Song Y; Zhang X; Huang K
Invest New Drugs; 2020 Apr; 38(2):321-328. PubMed ID: 31087222
[TBL] [Abstract] [Full Text] [Related]
10. Knockdown of foxo3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G
J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517
[TBL] [Abstract] [Full Text] [Related]
11. HH1-1, a novel Galectin-3 inhibitor, exerts anti-pancreatic cancer activity by blocking Galectin-3/EGFR/AKT/foxo3 signaling pathway.
Yao Y; Zhou L; Liao W; Chen H; Du Z; Shao C; Wang P; Ding K
Carbohydr Polym; 2019 Jan; 204():111-123. PubMed ID: 30366522
[TBL] [Abstract] [Full Text] [Related]
12. foxo3a Reverses the Cisplatin Resistance in Ovarian cancer.
Lu M; Chen X; Xiao J; Xiang J; Yang L; Chen D
Arch Med Res; 2018 Feb; 49(2):84-88. PubMed ID: 29716743
[TBL] [Abstract] [Full Text] [Related]
13. The foxo3/PGC-1β signaling axis is essential for cancer stem cell properties of pancreatic ductal adenocarcinoma.
Kumazoe M; Takai M; Hiroi S; Takeuchi C; Kadomatsu M; Nojiri T; Onda H; Bae J; Huang Y; Takamatsu K; Yamashita S; Kangawa K; Tachibana H
J Biol Chem; 2017 Jun; 292(26):10813-10823. PubMed ID: 28507102
[TBL] [Abstract] [Full Text] [Related]
14. Expression of PH Domain Leucine-rich Repeat Protein Phosphatase, Forkhead Homeobox Type O 3a and RAD51, and their Relationships with Clinicopathologic Features and prognosis in Ovarian Serous Adenocarcinoma.
Zhang J; Wang JC; Li YH; Wang RX; Fan XM
Chin Med J (Engl); 2017 Feb; 130(3):280-287. PubMed ID: 28139510
[TBL] [Abstract] [Full Text] [Related]
15. Inducible nitric oxide synthase enhances disease aggressiveness in pancreatic cancer.
Wang J; He P; Gaida M; Yang S; Schetter AJ; Gaedcke J; Ghadimi BM; Ried T; Yfantis H; Lee D; Weiss JM; Stauffer J; Hanna N; Alexander HR; Hussain SP
Oncotarget; 2016 Aug; 7(33):52993-53004. PubMed ID: 27367029
[TBL] [Abstract] [Full Text] [Related]
16. An Analysis of Prognostic Factors in Patients with Ovarian Malignant Germ Cell Tumors Who Are Treated with Fertility-Preserving Surgery.
Yang ZJ; Liu ZC; Wei RJ; Li L
Gynecol Obstet Invest; 2016; 81(1):1-9. PubMed ID: 25967958
[TBL] [Abstract] [Full Text] [Related]
17. KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of foxo3a.
Huang L; Wang HY; Li JD; Wang JH; Zhou Y; Luo RZ; Yun JP; Zhang Y; Jia WH; Zheng M
Cell Death Dis; 2013 Aug; 4(8):e745. PubMed ID: 23907459
[TBL] [Abstract] [Full Text] [Related]
18. The expression and prognosis of foxo3a and Skp2 in human ovarian cancer.
Lu M; Zhao Y; Xu F; Wang Y; Xiang J; Chen D
Med Oncol; 2012 Dec; 29(5):3409-15. PubMed ID: 22714061
[TBL] [Abstract] [Full Text] [Related]
19. The expression and significance of pThr32-foxo3a in human ovarian cancer.
Lu M; Xiang J; Xu F; Wang Y; Yin Y; Chen D
Med Oncol; 2012 Jun; 29(2):1258-64. PubMed ID: 21452041
[TBL] [Abstract] [Full Text] [Related]
20. Low expression of foxo3a is associated with poor prognosis in ovarian cancer patients.
Fei M; Zhao Y; Wang Y; Lu M; Cheng C; Huang X; Zhang D; Lu J; He S; Shen A
Cancer Invest; 2009 Jan; 27(1):52-9. PubMed ID: 19160093
[TBL] [Abstract] [Full Text] [Related]
[Next]
